11 employees
Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.
2012
$5M
from 3 investors over 3 rounds
Phoenix Molecular Designs raised $5M on November 20, 2019
Investors: The51 and -
Phoenix Molecular Designs raised $2.7M on September 18, 2018
Investors: -